Abstract:Two cases of hypnotic sequelae occurring in a research context (with a non-clinical college population) are reported. Case 1 was a male who experienced retroactive amnesia following hypnosis: He was unable to recall familiar telephone numbers later that day. This was not a continuation of an earlier confusion or drowsiness (as is often found) since he indicated he was wide awake following hypnosis. Two parallels exist with previous reports: unpleasant childhood experiences with chemical anesthesia and a confli… Show more
“…Another Grade 2 AE involved an 18-year-old female who had an apparent epileptic seizure while practicing hypnosis. A subsequent EEG was normal, and it was thought to likely be a spontaneous event given the absence of a personal or family history of seizures [ 25 ]. The last Grade 2 AE identified was a 17-year-old male who had increased symptoms of depression and reduced therapeutic engagement after biofeedback and progressive muscle relaxation for tension headaches ( Table 2 ) [ 36 ].…”
Section: Resultsmentioning
confidence: 99%
“…There were 20 AEs rated as Grade 1 (mild) ( Table 2 ). Seven adverse events were associated with the practice of hypnosis, including blue-tinted vision with a concurrent penile erection [ 21 ], increased anxiety, dissociated states, depersonalization phenomena [ 22 ], physical discomfort [ 23 , 27 ], and retroactive amnesia [ 25 ]. Relaxation had five adverse events associated with it, including four instances of increased betamimetic medication use [ 38 ] and an increase in tic frequency [ 31 ].…”
Mind-body interventions (MBIs) are one of the top ten complementary approaches utilized in pediatrics, but there is limited knowledge on associated adverse events (AE). The objective of this review was to systematically review AEs reported in association with MBIs in children. In this systematic review the electronic databases MEDLINE, Embase, CINAHL, CDSR, and CCRCT were searched from inception to August 2018. We included primary studies on participants ≤ 21 years of age that used an MBI. Experimental studies were assessed for whether AEs were reported on or not, and all other study designs were included only if they reported an AE. A total of 441 were included as primary pediatric MBI studies. Of these, 377 (85.5%) did not explicitly report the presence/absence of AEs or a safety assessment. There were 64 included studies: 43 experimental studies reported that no AE occurred, and 21 studies reported AEs. There were 37 AEs found, of which the most serious were grade 3. Most of the studies reporting AEs did not report on severity (81.0%) or duration of AEs (52.4%). MBIs are popularly used in children; however associated harms are often not reported and lack important information for meaningful assessment.
“…Another Grade 2 AE involved an 18-year-old female who had an apparent epileptic seizure while practicing hypnosis. A subsequent EEG was normal, and it was thought to likely be a spontaneous event given the absence of a personal or family history of seizures [ 25 ]. The last Grade 2 AE identified was a 17-year-old male who had increased symptoms of depression and reduced therapeutic engagement after biofeedback and progressive muscle relaxation for tension headaches ( Table 2 ) [ 36 ].…”
Section: Resultsmentioning
confidence: 99%
“…There were 20 AEs rated as Grade 1 (mild) ( Table 2 ). Seven adverse events were associated with the practice of hypnosis, including blue-tinted vision with a concurrent penile erection [ 21 ], increased anxiety, dissociated states, depersonalization phenomena [ 22 ], physical discomfort [ 23 , 27 ], and retroactive amnesia [ 25 ]. Relaxation had five adverse events associated with it, including four instances of increased betamimetic medication use [ 38 ] and an increase in tic frequency [ 31 ].…”
Mind-body interventions (MBIs) are one of the top ten complementary approaches utilized in pediatrics, but there is limited knowledge on associated adverse events (AE). The objective of this review was to systematically review AEs reported in association with MBIs in children. In this systematic review the electronic databases MEDLINE, Embase, CINAHL, CDSR, and CCRCT were searched from inception to August 2018. We included primary studies on participants ≤ 21 years of age that used an MBI. Experimental studies were assessed for whether AEs were reported on or not, and all other study designs were included only if they reported an AE. A total of 441 were included as primary pediatric MBI studies. Of these, 377 (85.5%) did not explicitly report the presence/absence of AEs or a safety assessment. There were 64 included studies: 43 experimental studies reported that no AE occurred, and 21 studies reported AEs. There were 37 AEs found, of which the most serious were grade 3. Most of the studies reporting AEs did not report on severity (81.0%) or duration of AEs (52.4%). MBIs are popularly used in children; however associated harms are often not reported and lack important information for meaningful assessment.
“…The adverse effects most extensively discussed in the literature in clinical practice include the emergence of strong affect (primarily anxiety); the encountering of unanticipated repressed/dissociated material (and/or spontaneous or uncontrollable abreactions); the discovery of problematic ego states; the onset of acute psychophysiological or somatoform symptoms (e.g., headaches, non-epileptic seizures); the onset of acute psychiatric decompensation (usually psychotic in nature); and difficulties with dehypnosis/realerting. These occurrences have been attributed to a number of factors (Gruzelier, 2000;Kluft, 2012aKluft, , 2012bKluft, , 2012cKluft, , 2012dLynn, Myer, & Mackillop, 2000;MacHovec, 1986;Page & Handley, 1990;1993). These include subject factors, such as hypnotizability, underlying psychopathology, and idiosyncratic understandings of the experiences of hypnosis.…”
Section: The Connection Between Adverse Reactions In Hypnosis and Incmentioning
Hypnosis has long demonstrated its power to facilitate various approaches to psychotherapy. Like other potent modalities, hypnosis may produce unwanted effects. Although its negative sequelae are usually mild and transient, more serious complications may occur. Recently, attention has been drawn to the powerful role of failures of dehypnosis or alerting/realerting in producing unwanted effects. Traditionally, alerting has been viewed as a relatively uncomplicated process that requires little more than the simple suggestion that the subject will return or awaken from trance, and exiting from trance has generally been considered the cessation of the phenomena suggested during induction and thereafter. Newer findings challenge these assumptions and suggest that restoring the subject to a prehypnotic baseline level of alertness is of equal or greater importance. Here, I describe the Howard Alertness Scale (HAS), with which subjects can be made aware of their baseline levels of alertness to help them understand the unique ways that their trance states differ from their normal alert states, and assess and measure their subjective perception of alertness before and after hypnosis. Furthermore, regular use of the HAS holds potential to enhance both the therapeutic alliance and the patient's sense of safety and mastery. The development and use of the HAS is discussed along with three vignettes illustrating its clinical application.
“…Participants had to meet all of the following criteria to be eligible for study enrollment: There has been one published report of a serious consequence related to hypnosis, a seizure in an 18-year-old with a history of epilepsy. 34 For this reason, individuals with a history of seizures or epilepsy were excluded from this study. Reports also suggest that hypnosis in individuals with a history of psychosis or psychotic depression may trigger psychiatric illnesses or produce decompensation or recurrent dissociative episodes.…”
Section: Therapeutic Hypnosis As An Interventionmentioning
Sickle cell disease (SCD) is the most common genetic disease in African-Americans, characterized by recurrent painful vaso-occlusive crises. Medical therapies for controlling or preventing crises are limited because of efficacy and/or toxicity. This is a randomized, controlled, single-crossover protocol of hypnosis for managing pain in SCD patients. Participants receive hypnosis from a trained hypnosis therapist followed by six weeks of self-hypnosis using digital media. Those in the control arm receive SCD education followed by a six-week waiting period before crossing over to the hypnosis arm of the study. Outcome measures include assessments of pain (frequency, intensity and quality), anxiety, coping strategies, sleep, depression, and health care utilization. To date, there are no published randomized, controlled trials evaluating the efficacy of hypnosis on SCD pain modulation in adults. Self-hypnosis for pain management may be helpful in modulating chronic pain, improving sleep quality, and decreasing use of narcotics in patients with SCD.TRIAL REGISTRATIONClinicalTrials.gov: NCT00393250
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.